Free Trial
NASDAQ:DRMA

Dermata Therapeutics (DRMA) Stock Price, News & Analysis

$1.93
-0.06 (-2.99%)
(As of 10:04 AM ET)
Today's Range
$1.93
$1.93
50-Day Range
$1.99
$5.70
52-Week Range
$1.80
$24.60
Volume
2,314 shs
Average Volume
54,617 shs
Market Capitalization
$1.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
DRMA stock logo

About Dermata Therapeutics Stock (NASDAQ:DRMA)

Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of anxillary hyperhidrosis and aesthetic conditions. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

DRMA Stock Price History

DRMA Stock News Headlines

Exposed: 3 CENT Crypto to Explode June 24th?
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…
Dermata Therapeutics, Inc. (DRMAW)
Dermata Therapeutics Inc DRMA
Exposed: 3 CENT Crypto to Explode June 24th?
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…
Why Is Dermata Therapeutics (DRMA) Stock Up 62% Today?
See More Headlines
Receive DRMA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/15/2024
Today
7/18/2024
Next Earnings (Estimated)
8/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:DRMA
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Net Income
$-7,800,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$24.24 per share

Miscellaneous

Free Float
509,000
Market Cap
$1.11 million
Optionable
Not Optionable
Beta
0.75
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Gerald T. Proehl (Age 65)
    Founder, President, CEO & Chairman
    Comp: $392k
  • Mr. David F. Hale (Age 75)
    Co-Founder & Lead Independent Director
    Comp: $73k
  • Ms. Kyri K. Van Hoose CPA (Age 46)
    M.B.A., Senior VP & CFO
    Comp: $415.8k
  • Dr. Christopher J. Nardo M.P.H. (Age 59)
    Ph.D., Senior VP & Chief Development Officer
    Comp: $443.52k
  • Mr. Sean Proehl
    Senior Director of Legal & Business Development
  • Dr. Maria Bedoya Toro Munera M.B.A. (Age 73)
    Ph.D., Senior Vice President of Regulatory Affairs & Quality Assurance
    Comp: $27.04k

DRMA Stock Analysis - Frequently Asked Questions

How have DRMA shares performed this year?

Dermata Therapeutics' stock was trading at $9.15 on January 1st, 2024. Since then, DRMA shares have decreased by 78.6% and is now trading at $1.96.
View the best growth stocks for 2024 here
.

How were Dermata Therapeutics' earnings last quarter?

Dermata Therapeutics, Inc. (NASDAQ:DRMA) issued its quarterly earnings results on Wednesday, May, 15th. The company reported ($7.05) EPS for the quarter.

When did Dermata Therapeutics' stock split?

Dermata Therapeutics's stock reverse split before market open on Thursday, May 16th 2024. The 1-15 reverse split was announced on Thursday, May 16th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 16th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

When did Dermata Therapeutics IPO?

Dermata Therapeutics (DRMA) raised $18 million in an IPO on Friday, August 13th 2021. The company issued 2,571,428 shares at a price of $7.00 per share.

How do I buy shares of Dermata Therapeutics?

Shares of DRMA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DRMA) was last updated on 7/18/2024 by MarketBeat.com Staff

From Our Partners